05.01.2013 Views

Download PDF version - Bisnode

Download PDF version - Bisnode

Download PDF version - Bisnode

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

38<br />

asset’s carrying amount exceeds its recoverable amount. The recoverable<br />

amount is the higher of an asset’s fair value less costs to sell and value in use. For<br />

the purposes of assessing impairment, assets are grouped at the lowest levels for<br />

which there are separately identifiable cash flows (cash generating units).<br />

2.10 Financial assets<br />

The Group classifies its financial assets in the following categories: at fair value<br />

through profit or loss, loans and receivables, and available-for-sale financial<br />

assets. The classification depends on the purpose for which the financial assets<br />

were acquired. Management determines the classification of its financial assets at<br />

initial recognition and reviews the classificiation at each reporting date.<br />

a) Financial assets at fair value through profit or loss<br />

Financial assets at fair value through profit or loss are financial assets held for<br />

trading. A financial asset is classified in this category if acquired principally for the<br />

purpose of selling in the short term. Derivatives are also categorised as held for<br />

trading unless they are designated as hedges. Assets in this category are classified<br />

as current assets if expected to be settled within 12 months; otherwise, they are<br />

classified as non-current. During the financial year, the Group had no assets<br />

belonging to this category.<br />

b) Loans and receivables<br />

Loans and receivables are non-derivative financial assets with fixed or determinable<br />

payments that are not quoted in an active market. They characteristically arise<br />

when the Group supplies money, goods or services directly to a customer without<br />

intending to trade with the claim that has arisen. They are included in current<br />

assets, except for maturities greater than 12 months after the balance sheet date.<br />

These are classified as non-current assets. This category includes trade and other<br />

receivables in the balance sheet.<br />

c) Available-for-sale financial assets<br />

Available-for-sale financial assets are non-derivatives that are either designated in<br />

this category or not classified in any of the other categories. They are included in<br />

non-current assets unless management intends to dispose of the investment<br />

within 12 months of the balance sheet date.<br />

Regular purchases and sales of financial assets are recognised on the tradedate<br />

– the date on which the Group commits to purchase or sell the asset. Investments<br />

are initially recognised at fair value plus transaction costs, for all financial<br />

assets not carried at fair value through profit or loss. Financial instruments are<br />

derecognised when the rights to receive cash flows from the investments have<br />

expired or have been transferred and the Group has transferred substantially all<br />

risks and rewards of ownership. Available-for-sale financial assets and financial<br />

assets at fair value through profit or loss are subsequently carried at fair value.<br />

Realised and unrealised gains or losses arising from changes in the fair value of<br />

the financial assets at fair value through profit or loss are presented in the income<br />

statement in the period in which they arise. Unrealised gains or losses arising from<br />

changes in the fair value of instruments classified as available-for-sale are recognised<br />

in other comprehensive income. When instruments classified as available-for-sale<br />

are sold or impaired, the accumulated fair value adjustments are included in the<br />

income statement as gains and losses from financial instruments.<br />

The fair values of quoted investments are based on current bid prices. If the<br />

market for a specific financial asset is not active (and for unlisted securities), the<br />

Group establishes fair value by using valuation techniques. These include the use<br />

of recent arm’s length transactions, reference to other instruments that are substantially<br />

the same, discounted cash flow statement and option pricing models<br />

that have been refined to reflect the issuer’s special conditions.<br />

The Group assesses at each balance sheet date whether there is objective<br />

evidence that a financial asset or a group of financial assets is impaired. If any<br />

such evidence exists for available-for-sale financial assets, the cumulative loss –<br />

measured as the difference between the historical cost and the current fair value,<br />

less any impairment loss on that financial asset previously recognised in profit or<br />

loss – is removed from equity and recognised in the income statement. Impairment<br />

losses recognised in the income statement on equity instruments are not reversed<br />

through the income statement.<br />

2.11 Derivative financial instruments<br />

Derivatives are initially recognised at fair value on the date a derivative contract is<br />

entered into and are subsequently remeasured at their fair value. The method of<br />

recognising the resulting gain or loss depends on whether the derivative is designated<br />

as a hedging instrument, and if so, the nature of the item being hedged.<br />

The Group designates certain derivatives as either: (1) hedges of the fair value of<br />

recognised liabilities (fair value hedge); (2) hedges of a particular risk associated<br />

with a recognised liability or a highly probable forecast transaction (cash flow<br />

hedge); or (3) hedges of a net investment in a foreign operation (net investment<br />

hedge). As of balance sheet date, the Group uses only cash flow hedges.<br />

The Group documents, at the inception of the transaction, the relationship<br />

between hedging instruments and hedged items, as well as its risk management<br />

objectives and strategy for undertaking various hedging transactions. The Group<br />

also documents its assessment, both at hedge inception and on an ongoing<br />

basis, of whether the derivatives that are used in hedging transactions are highly<br />

effective in offsetting changes in fair values or cash flows of hedged items.<br />

Cash flow hedges<br />

The effective portion of changes in the fair value of derivatives that are designated<br />

and qualify as cash flow hedges is recognised in other comprehensive<br />

income. The gain or loss relating to the ineffective portion is recognised immediately<br />

in the income statement as financial income or expense.<br />

Amounts accumulated in equity are recycled in the income statement in the<br />

periods when the hedged item affects profit or loss.<br />

When a hedging instrument expires or is sold, or when a hedge no longer<br />

meets the criteria for hedge accounting, any cumulative gain or loss existing in<br />

equity at the time remains in equity and is recognised when the forecast transaction<br />

is ultimately recognised in the income statement. When a forecast transaction is<br />

no longer expected to occur, the cumulative gain or loss that was reported in<br />

equity is immediately transferred to the income statement.<br />

2.12 Inventories<br />

Inventories are stated at the lower of cost and net realisable value. Cost is determined<br />

using the first-in, first-out (FIFO) method. The cost of finished goods and<br />

work in progress comprises design costs, raw materials, direct labour, other<br />

direct costs and related production overheads (based on normal operating<br />

capacity). It excludes borrowing costs. Net realisable value is the estimated selling<br />

price in the ordinary course of business, less applicable variable selling expenses.<br />

2.13 Trade receivables<br />

Trade receivables are recognised initially at fair value, less provision for impairment.<br />

A provision for impairment of trade receivables is established when there is objective<br />

evidence that the Group will not be able to collect all amounts due according to<br />

the original terms of the receivables. The amount of the provision is the difference<br />

between the asset’s carrying amount and the present value of the estimated<br />

future cash flows. The provision is recognised in the income statement among<br />

other expenses.<br />

2.14 Cash and cash equivalents<br />

Cash and cash equivalents includes cash in hand, deposits held at call with banks<br />

and any short-term investments. Short-term investments consist of securities<br />

with maturities of less than three months.<br />

2.15 Borrowings<br />

Borrowings are recognised initially at fair value, net of transaction costs incurred.<br />

Borrowings are subsequently stated at amortised cost. Any difference between<br />

the proceeds (net of transaction costs) and the redemption value is recognised in<br />

the income statement over the period of the borrowings using the effective interest<br />

method.<br />

Borrowings are classified as current liabilities unless the Group has an unconditional<br />

right to defer settlement of the liability for at least 12 months after the balance<br />

sheet date.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!